Swan Capital’s Constellium CSTM Stock Holding History

Swan Capital’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$471	–	570
2025 Q4	$471	Hold	25	–	–	﹤0.01%	455
2025 Q3	$372	Buy	+25	New	+$358	﹤0.01%	446

Other funds holding CSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Swan Capital's CSTM Position: Q1 2026 in Review

Swan Capital sold out of Constellium (CSTM) in Q1 2026, closing a stake of 25 shares — an estimated $471 sold.

Swan Capital first reported a position in CSTM in Q3 2025 and held it in 2 quarters. The position peaked at $471 in Q4 2025. 314 funds tracked by Wall St. Rank hold CSTM as of Q1 2026.

Swan Capital reported no remaining Constellium position as of Q1 2026 after selling out during the quarter.
Swan Capital sold 25 Constellium shares in Q1 2026, an estimated $471.
Swan Capital first reported a position in Constellium in Q3 2025 and held it in 2 quarters.
Swan Capital's Constellium position peaked at $471 in Q4 2025.
314 funds tracked by Wall St. Rank held Constellium as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.